GGM Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
GGM Wealth Advisors's PFE Position: Q1 2025 in Review
GGM Wealth Advisors reduced its Pfizer (PFE) stake by 1.4% in Q1 2025, selling an estimated $7.69K and leaving 20,816 shares worth $480K. The position accounts for 0.27% of the portfolio, ranked #76.
GGM Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.8M in Q4 2022. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- GGM Wealth Advisors held 20,816 shares of Pfizer worth $480K as of Q1 2025.
- GGM Wealth Advisors sold 294 Pfizer shares in Q1 2025, an estimated $7.69K.
- Pfizer made up 0.27% of GGM Wealth Advisors's portfolio in Q1 2025, its #76 holding.
- GGM Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- GGM Wealth Advisors's Pfizer position peaked at $1.8M in Q4 2022.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on GGM Wealth Advisors's 13F filing for Q1 2025, filed 1 May 2025.